These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 2146664)

  • 21. Oral spironolactone therapy for female patients with acne, hirsutism or androgenic alopecia.
    Burke BM; Cunliffe WJ
    Br J Dermatol; 1985 Jan; 112(1):124-5. PubMed ID: 3155956
    [No Abstract]   [Full Text] [Related]  

  • 22. Comparison of sequential cyproterone acetate/estrogen versus spironolactone/oral contraceptive in the treatment of hirsutism.
    O'Brien RC; Cooper ME; Murray RM; Seeman E; Thomas AK; Jerums G
    J Clin Endocrinol Metab; 1991 May; 72(5):1008-13. PubMed ID: 1827125
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Low dose spironolactone in the treatment of female hyperandrogenemia and hirsutism.
    Vĕtr M; Sobek A
    Acta Univ Palacki Olomuc Fac Med; 1993; 135():55-7. PubMed ID: 7976677
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Spironolactone in dermatologic therapy.
    Shaw JC
    J Am Acad Dermatol; 1991 Feb; 24(2 Pt 1):236-43. PubMed ID: 1826112
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of the clinical efficacy of flutamide and spironolactone plus ethinyloestradiol/cyproterone acetate in the treatment of hirsutism: a randomised controlled study.
    Karakurt F; Sahin I; Güler S; Demirbas B; Culha C; Serter R; Aral Y; Bavbek N
    Adv Ther; 2008 Apr; 25(4):321-8. PubMed ID: 18389188
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The effectiveness of oral cyproterone acetate in combination with ethinylestradiol in acne tarda of the facial type].
    Gollnick H; Albring M; Brill K
    Ann Endocrinol (Paris); 1999 Sep; 60(3):157-66. PubMed ID: 10520404
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hormonal therapy for acne: why not as first line therapy? facts and controversies.
    Katsambas AD; Dessinioti C
    Clin Dermatol; 2010; 28(1):17-23. PubMed ID: 20082945
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of the combination spironolactone-norgestimate-estrogen in Hirsute women with polycystic ovary syndrome.
    Hagag P; Steinschneider M; Weiss M
    J Reprod Med; 2014; 59(9-10):455-63. PubMed ID: 25330687
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Spironolactone is an effective and well tolerated systemic antiandrogen therapy for Hirsute women.
    Barth JH; Cherry CA; Wojnarowska F; Dawber RP
    J Clin Endocrinol Metab; 1989 May; 68(5):966-70. PubMed ID: 2715294
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Oral and topical spironolactone therapies in skin androgenization.
    Messina M; Manieri C; Musso MC; Pastorino R
    Panminerva Med; 1990; 32(2):49-55. PubMed ID: 2147469
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of spironolactone, flutamide, and finasteride efficacy in the treatment of hirsutism: a randomized, double blind, placebo-controlled trial.
    Moghetti P; Tosi F; Tosti A; Negri C; Misciali C; Perrone F; Caputo M; Muggeo M; Castello R
    J Clin Endocrinol Metab; 2000 Jan; 85(1):89-94. PubMed ID: 10634370
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Therapeutic evaluation of spironolactone in Indian women with hirsutism.
    Buckshee K; Ahuja MM
    J Assoc Physicians India; 1986 Aug; 34(8):577-9. PubMed ID: 3793679
    [No Abstract]   [Full Text] [Related]  

  • 33. Spironolactone in Dermatology: Uses in Acne, Hidradenitis Suppurativa, Female Pattern Baldness, and Hirsutism.
    Vargas-Mora P; Morgado-Carrasco D
    Actas Dermosifiliogr (Engl Ed); 2020 Oct; 111(8):639-649. PubMed ID: 32571540
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hirsutism--a low dose spironolactone therapy.
    Vĕtr M
    Acta Univ Palacki Olomuc Fac Med; 1989; 122():239-45. PubMed ID: 2530821
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Indications and limits of anti-androgen therapy].
    Zaun H
    Z Hautkr; 1984 Aug; 59(16):1090-7. PubMed ID: 6207673
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of hirsutism with spironolactone.
    Tremblay RR
    Clin Endocrinol Metab; 1986 May; 15(2):363-71. PubMed ID: 2941190
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects and side-effects of spironolactone therapy in women with acne.
    Yemisci A; Gorgulu A; Piskin S
    J Eur Acad Dermatol Venereol; 2005 Mar; 19(2):163-6. PubMed ID: 15752283
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of finasteride versus spironolactone in the treatment of idiopathic hirsutism.
    Erenus M; Yücelten D; Durmuşoğlu F; Gürbüz O
    Fertil Steril; 1997 Dec; 68(6):1000-3. PubMed ID: 9418687
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of spironolactone and spironolactone plus finasteride in the treatment of hirsutism.
    Unlühizarci K K; Everest H; Bayram F; Keleştimur F
    Fertil Steril; 2002 Dec; 78(6):1331-3. PubMed ID: 12477537
    [No Abstract]   [Full Text] [Related]  

  • 40. [Spironolactone in idiopathic hirsutism, clinical and biological evaluation of treatment].
    Abramovici Y; Guillet F; Matte R; Chaieb L; Belanger R
    Ann Endocrinol (Paris); 1983; 44(6):393-6. PubMed ID: 6430208
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.